NCT05813054

Clinical Study to Evaluate the Anti-aging Efficacy of Dermial®

Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Anti-aging Efficacy of Dermial®

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Bioiberica · Industry
• Sex: All
• Age: 35 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Oral supplement with an HA matrix ingredient composed of HA (60-75%), sulfated GAGs (≥10%), including DS and CS, and collagen (≥ 5%) to evaluate the hydration of the stratum corneum of facial skin in healthy women showing natural signs of age-related aging versus placebo

Detailed description

This study includes 60 healthy volunteers in which will be evaluated if the oral supplement with Dermial \[composed of HA (60-75%), sulfated GAGs (≥10%), including DS and CS, and collagen (≥ 5%)\] is able to obtain differences versus placebo in healthy women showing natural signs of age-related aging versus placebo . It is a single-center, double-blind, randomized, placebo-controlled clinical study with proportion 1:1 between treatments.

Conditions

• Skin Aging

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	HA matrix ingredient	1 capsule/day
DIETARY_SUPPLEMENT	Placebo	1 capsule/day

Timeline

• Start date: 2022-10-01
• Primary completion: 2023-03-15
• Completion: 2023-09-15
• First posted: 2023-04-14
• Last updated: 2024-08-27

Locations

1 site across 1 country: Spain